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Abstract
Background: MCF-7 breast cancer cell line is undoubtedly amongst the most extensively studied patient-derived
research models, providing pivotal results that have over the decades translated to constantly improving patient
care. Many research groups, have previously identified suitable reference genes for qPCR normalization in MCF-7
cell line. However, over the course of identification of suitable reference genes, a comparative analysis comprising
these genes together in a single study has not been reported. Furthermore, the expression dynamics of these
reference genes within sub-clones cultured over multiple passages (p) has attracted limited attention from research
groups. Therefore, we investigated the expression dynamics of 12 previously suggested reference genes within two
sub-clones (culture A1 and A2) cultured identically over multiple passages. Additionally, the effect of nutrient stress
on reference gene expression was examined to postulate an evidence-based recommendation of the least variable
reference genes that could be employed in future gene expression studies.
Results: The analysis revealed the presence of differential reference gene expression within the sub-clones of MCF-
7. In culture A1, GAPDH-CCSER2 were identified as the least variable reference genes while for culture A2, GAPDH-
RNA28S were identified. However, upon validation using genes of interest, both these pairs were found to be
unsuitable control pairs. Normalization of AURKA and KRT19 with triplet pair GAPDH-CCSER2-PCBP1 yielded successful
results. The triplet also proved its capability to handle variations arising from nutrient stress.
Conclusions: The variance in expression behavior amongst sub-clones highlights the potential need for exercising
caution while selecting reference genes for MCF-7. GAPDH-CCSER2-PCBP1 triplet offers a reliable alternative to
otherwise traditionally used internal controls for optimizing intra- and inter-assay gene expression differences.
Furthermore, we suggest avoiding the use of ACTB, GAPDH and PGK1 as single internal controls.
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Background
MCF-7 (Michigan Cancer Foundation 7) is one of the most
commonly used patient derived breast cancer cell line.
Established in 1970 by researcher Herbert D. Soule at the
Michigan Cancer Foundation, the cell line is derived from
the pleural effusion and chest wall nodule showing metasta-
sis of breast adenocarcinoma. The number 7 in MCF-7 rep-
resents Soule’s seventh attempt in which he succeeded in
generating a cancer cell line [1]. The universal adoption of
the cell line is evident from a simple PubMed search
(Search word: MCF-7) which retrieves about 39,000 cita-
tions (from 1973 to March 2020) with about 900 citations
being reported in the first three months of 2020 alone.
In 2013, an updated approach based on IHC (immuno-
histochemistry) markers was introduced by St. Gallen
International Expert Consensus on Primary Therapy of
Early Breast Cancer to determine subtypes of breast can-
cers [2]. Accordingly, Luminal A subtype tumors were de-
fined as Estrogen Receptor positive (ER+), Progesterone
Receptor (PR) ≥ 20%, HER2 negative, Ki67 proliferation
marker < 14% and if available, low recurrence risk tumors
based on gene-based assays [2]. MCF-7 neoplastic cells
were found to be positive for both Estrogen (ER) and Pro-
gesterone (PR) receptors along with having low metastatic
activity and hence, fulfilled the criteria to be classified as
Luminal A molecular subtype tumor cell line [3].
Cell based assays (cell lines) such as MCF-7 represents
techniques that can provide more biologically meaning-
ful information than simplified biochemical assays [4].
The key reasons for their universal adoption are lower
operational costs and the ease of operation in terms of
preparing and observing the cells. Furthermore, they
represent an unlimited self-replicating source that can
be grown in almost infinite quantities [5] yielding unlim-
ited amounts of DNA/RNA that enables studies related
to validation and downstream functional analysis.
However, MCF-7 cell line, like other cell lines is prone
to certain disadvantages. It is vulnerable to genotypic
and phenotypic drift during its long-term culturing [5].
This is of profound concern since the cell line has been
deposited in cell banks for many years now and has
risked and in some certain cases caused arising of sub-
populations within the cell line. Subpopulations can
cause phenotypic changes over time with the selection
of specific, more rapidly growing clones within a popula-
tion, as demonstrated by Osborne et al. [6] and Resnicoff
et al. [7] in 1987.
For decades, extensive evidence that MCF-7 cells
showed clonal variations have been reported, depicting
differences in phenotypic traits such as estrogen/proges-
terone responsiveness, epidermal growth factor (EGF)
expression or the ability to form tumors in syngeneic
mice [8]. Also, genetic variability in the sublines and
sub-clones of MCF-7 cell line on karyotypic and
chromosomal levels have been demonstrated by various
researchers [9–15]. Finally, in 2016 Kleensang et al., il-
lustrated variations among MCF-7 cell line obtained
from the same cell bank in the same batch [16]. Pres-
ence of such heterogeneity bolsters the need for validat-
ing and cross-examining the genetic variability as well as
reference gene expression in the cell line.
A widely accepted technique for validation of gene ex-
pression is the Reverse Transcription – quantitative
Polymerase Chain Reaction (RT-qPCR). It is a simple,
highly sensitive, reproducible, and high yielding through-
put technique that can confirm gene expression differ-
ences and measure transcript abundances [17, 18].
Nevertheless, the results obtained from RT- qPCR still
need to be normalized against another data set or set
references to correct for any sampling noise, such as dif-
ferences in the amount of starting material, in order to
estimate results accurately [19].
These reference genes (previously housekeeping genes)
are expressed constitutively and are required for the main-
tenance of basal cellular functions. In general practice, it is
presumed that the endogenous reference gene represents
an ideal gene that is sufficiently abundant and has stable
expression across different tissues and cell lines under dif-
ferent experimental conditions [20]. In addition, it is as-
sumed that the expression levels remain same amongst
biological replicate cell cultures over successive passages.
However, some studies suggest that the expression of
these reference genes may not be as uniform as previously
thought and may also fluctuate significantly under differ-
ent experimental conditions [21, 22]. Hence, it becomes
imperative to validate reference genes before their use in a
study as using a non-validated reference gene could lead
to misleading interpretations arising from inaccurate re-
sults [20, 23].
As pointed out in the MIQE guidelines [24], normalization
against a single reference gene is not recommended unless
clear evidence of its uniform expression dynamics is de-
scribed for the specific experimental conditions. Over the
previous two decades, many studies have been undertaken
identifying new stable reference genes for MCF-7 cell line or
breast cancer as a whole [25–32].
However, these studies didn’t undertake a detailed ana-
lysis validating the reference gene expression over multiple
passages and/or, within sub-clones (biological replicate
cultures). This gap in validation leaves us with a cause of
concern especially, if such cell lines are to be regarded as
valid and suitable models for evaluating the behavior and
development of breast cancer and validating their likely
response to potential new drugs and therapies.
The present study, therefore, aims to fill the void by
investigating the gene expression of twelve reference
genes that were previously identified as stable genes by
various studies [25–28, 33–37] for MCF-7 cell line, but
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were not accounted and studied together and therefore,
were unable to make an evidence supported recommenda-
tion of reference genes to be used for normalization of the
gene of interest in MCF-7 cell line cultured routinely as
well in nutrient stress conditions. The present study investi-
gated the differential reference gene expression in two sub-
clones (culture A1 and A2) cultured identically over mul-
tiple passages (p). Additionally, the effect of nutrient stress
on reference gene expression was examined to further bol-
ster the selection of reference genes.
Results
Curation of the dataset and descriptive analysis
A total of three lysates were collected from each passage
from both MCF-7 cultures A1 and A2. Only two lysates
were evaluated for passage 28 (p28) and passage 31 (p31)
from culture A1. Amplification for each of the 12 reference
genes produced a dataset with 900 Cq values. As shown in
Table 1, RNA18S showed the highest expression in both
cultures A1 and A2 (Cq mean = 7.93 and 8.26 respectively),
closely followed by RNA28S (Cq mean = 8.27 and 8.35 re-
spectively). Both genes showed high amplification levels,
appearing close to seven cycles earlier than any other gene
in both cultures (ACTB Cq mean = 15.98 and 16.11 re-
spectively). CCSER2 presented the least expression levels in
both cultures (Cq mean = 26.58 and 26.56 respectively)
while GAPDH showed the least standard deviation (S.D =
0.30) in culture A1. ACTB showed the least standard devi-
ation (S.D = 0.32) in culture A2. The largest variation be-
tween Cq values was shown by HNRNPL (S.D = 0.35) in
culture A1 and PGK1 (S.D = 0.61) in culture A2.
Coefficient of variation (CV%)
As shown in Table 2, across both cultures, the CV% was
in the range of 14.89 to 40.11% indicating that all the
candidate reference genes were characterized by stable
expression. The CV% analysis revealed that PCBP1 was
the only gene to be in the top three stable genes (CV% =
14.89% (A1) and 24.90% (A2)) in both the cultures.
Apart from PCBP1, the other two top stable genes in
culture A1 were GAPDH (CV% = 12.35%) and PGK1
(CV% = 14.86%), while in culture A2 those were ACTB
(CV% = 22.98%) and RNA28S (CV% = 24.52%). In stark
contrast, PGK1 in culture A2 was the least stable gene
(CV = 40.11%) showing variations in gene expression be-
tween the two cultures.
Relative mean changes in expression profiles of selected
candidate reference genes
Relative mean changes in expression profiles were ana-
lyzed to study the gene expression stability and varia-
tions over successive passages in the both cultures.
Passage 28 (p28) was selected as the experimental cali-
brator for culture A1 while Passage 25 (p25) was se-
lected as the calibrator for culture A2, since they
represented the initial investigated passages in both cul-
tures. The fold change was then calculated using 2-Cq
with the other passages in both cultures (Figs. 1 and 2).
To determine significant relative expression changes,
one-way ANOVA was used (Supplementary Table S1,
see Additional file 1). In culture A1, only CCSER2
(Fig. 2c) and PCBP1 (Fig. 2e) showed no significant ex-
pression changes over successive passages (ANOVA P >
0.05). In culture A2, all the genes selected, including
CCSER2 and PCBP1 showed significant expression
changes over successive passages. Both ACTB (Fig. 1a)
and GAPDH (Fig. 1b), along with PGK1 (Fig. 1d) showed
significant expression differences (ANOVA P < 0.01) in
both cultures over successive passages, providing evidence
Table 1 Descriptive Statistics of the Reference Genes Cq (Quantification Cycle) Values
Gene N a Mean Cq ± S.D b Minimum Cq Maximum Cq
A1 A2 A1 A2 A1 A2 A1 A2
ACTB 30 45 15.98 ± 0.26 16.11 ± 0.32 15.38 15.53 16.45 16.62
GAPDH 30 45 17.13 ± 0.17 17.07 ± 0.39 16.78 16.43 17.52 17.67
RPL13A 30 45 21.03 ± 0.29 20.74 ± 0.43 20.71 20.14 21.64 21.70
PGK1 30 45 21.08 ± 0.22 21.09 ± 0.61 20.79 20.29 21.76 22.11
HSPCB 30 45 20.40 ± 0.29 20.42 ± 0.51 20.02 19.70 20.98 21.77
RNA28S 30 45 8.27 ± 0.23 8.35 ± 0.40 7.61 7.83 8.64 9.58
RNA18S 30 45 7.93 ± 0.27 8.26 ± 0.49 7.45 7.58 8.47 9.83
PUM1 30 45 23.14 ± 0.23 23.08 ± 0.39 22.73 22.35 23.68 24.23
CCSER2 30 45 26.58 ± 0.21 26.56 ± 0.39 26.04 26.03 26.95 27.32
HNRNPL 30 45 22.73 ± 0.35 22.91 ± 0.56 22.11 21.97 23.52 23.99
PCBP1 30 45 22.13 ± 0.22 22.17 ± 0.37 21.78 21.65 22.76 22.94
SF3A1 30 45 23.39 ± 0.34 23.51 ± 0.43 22.99 22.78 24.28 24.68
a N – Total number of Cq values from all triplicates of three lysates. b S.D – Standard Deviation
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using these genes as single control endogenous reference
genes in MCF-7 cell line should be avoided, if possible.
NormFinder analysis of MCF-7 sub-clones
GAPDH showed the highest expression stability in both
cultures A1 and A2 (S.D = 0.14 and 0.16 respectively) as
shown in Fig. 3. It was followed by PCBP1 and CCSER2 in
culture A1 (S.D = 0.17) while in culture A2, it was
matched by RNA18S (S.D = 0.16). The algorithm was fur-
ther used to evaluate the pair of genes best suited to work
together as reference genes as shown in Supplementary
Table S2 (see Additional file 1) (only the top 10 pairs for
both the cultures with their pairwise standard deviations
shown). The algorithm ranked ACTB and PUM1 as the
most stable pair (S.D = 0.07) in culture A1, while in cul-
ture A2, two pairs of genes were equally most stable–
RPL13A – SF3A1 and GAPDH – SF3A1 (S.D = 0.07).
geNorm analysis and determination of optimal number of
genes needed for normalization of dataset
As shown in Fig. 4, there were noticeable differences in the
obtained results for both cultures. In culture A1, ACTB-
HSPCB was the most stable gene (M= 0.169; Fig. 4a) while
in culture A2, RNA18S-RNA28S tied for the most stable
gene (M= 0.177; Fig. 4b). geNorm was further used to de-
termine the optimal number of reference genes needed for
an accurate estimation of normalization of expression data,
as shown in Fig. 5. For both the cultures A1 and A2, the
V2/3 (0.00437 and 0.00468 respectively) was less than the
recommended cutoff (Vn/Vn+ 1 < 0.15), indicating the
addition of a third reference gene would not make a differ-
ence in the normalization results.
BestKeeper analysis
In the present study, first we considered the standard de-
viation with crossing points (C.P) for both cultures (Fig. 6a
and b). As seen in the two previous methods (NormFinder
and geNorm), BestKeeper also showed deviations in re-
sults for both cultures A1 and A2. While GAPDH (S.D =
0.14) and CCSER2 (S.D = 0.18) were the top two genes in
culture A1, ACTB (S.D = 0.28) and RNA28S (S.D = 0.30)
were top two genes in culture A2. The standard deviation
with changes in x-fold were also examined as shown in
Supplementary Table S3 (see Additional file 1). The mini-
mum and maximum fold change (x-fold) obtained from
Table 2 Mean 2-Cq, Standard Deviation (S.D) 2-Cq and CV% of the candidate reference genes
Candidate Reference Gene MCF-7 Replicate Culture Mean 2-Cq S.D 2-Cq CV (S.D/Mean)
ACTB A1 1.6E-05 2.9E-06 18.81%
A2 1.4E-05 3.3E-06 22.98%
GAPDH A1 7.0E-06 8.7E-07 12.35%
A2 7.5E-06 2.0E-06 26.84%
RPL13A A1 4.7E-07 8.7E-08 18.39%
A2 5.9E-07 1.6E-07 26.71%
PGK1 A1 4.5E-07 6.7E-08 14.86%
A2 4.9E-07 2.0E-07 40.11%
HSPCB A1 7.4E-07 1.4E-07 19.34%
A2 7.5E-07 2.4E-07 31.31%
RNA28S A1 3.3E-03 5.8E-04 17.66%
A2 3.1E-03 7.7E-04 24.52%
RNA18S A1 4.2E-03 8.0E-04 19.17%
A2 3.4E-03 9.9E-04 28.97%
PUM1 A1 1.1E-07 1.7E-08 15.65%
A2 1.2E-07 2.9E-08 25.03%
CCSER2 A1 1.0E-08 1.6E-09 15.55%
A2 1.0E-08 2.7E-09 25.65%
HNRNPL A1 1.5E-07 3.5E-08 23.70%
A2 1.4E-07 5.2E-08 38.21%
PCBP1 A1 2.2E-07 3.3E-08 14.89%
A2 2.2E-07 5.5E-08 24.90%
SF3A1 A1 9.3E-08 2.0E-08 21.20%
A2 8.7E-08 2.4E-08 27.76%
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BestKeeper were in concordance with our results from
relative mean fold changes (Figs. 1 and 2).
Finally, coefficient of correlation (r) given as Pearson’s correl-
ation by BestKeeper was evaluated to look for pairwise gene ex-
pression stability in both cultures (Fig. 7a and b). The top five
gene pairs with high positive coefficient of correlation (r > 0.5)
in culture A1 (Fig. 7a) were HSPCB-ACTB (r = 0.833),
RPL13A-RNA18S (r = 0.825), PGK1-HSPCB (r = 0.775), PUM1-
PCBP1 (r = 0.704) and PUM1-SF3A1 (r = 0.598). Similarly,
upon analysis of gene pairs in culture A2 (Fig. 7b), the top five
gene pairs with r > 0.5 were, PGK1-HNRNPL (r = 0.948),
RNA28S- RNA18S and PGK1-GAPDH (both pairs with r=
0.946), PCBP1-SF3A1 (r = 0.933) and PGK1-HSPCB (r = 0.908).
Pairwise comparative ΔCt analysis of the MCF-7 sub-
clones
In culture A1, GAPDH, CCSER2 and PCBP1 were the
top three genes ranked by the algorithm while in culture
A2, RNA28S, GAPDH and PCBP1 were the top three
genes (Supplementary Table S4, see Additional file 1). It
is interesting to note that in culture A1, the three top
genes ranked by Comparative ΔCt were ranked in the
same position and order by BestKeeper (Fig. 6a). In cul-
ture A2, only RNA28S was reported in the top three by
both these algorithms (Supplementary Table S4; Fig. 6a).
RefFinder analysis
RefFinder is a comprehensive, user friendly, web based tool
(https://www.heartcure.com.au/reffinder/) that uses NormFin-
der, geNorm, BestKeeper and Comparative ΔCt to rank and
compare candidate reference genes. The rankings from RefFin-
der are summarized in Supplementary Table S5 (see Additional
file 1). The top three genes in culture A1 were reported to be
GAPDH, CCSER2 and PCBP1. For culture A2, RNA28S,
GAPDH and PCBP1 were the top three most stable genes.
Moving towards selection of reference gene/s based on
an integrated approach
Based on the results from above reported algorithms
and approaches, we conclude that for culture A1, GAPD
Fig. 1 Relative change of expression of the candidate genes (a) ATCB (b) GAPDH (c) RPL13A (d) PGK1 (e) HSPCB and (f) RNA28S over successive
passages in both cultures A1 and A2. The expression change was measured as 2-Cq with the experimental calibrators marked as gray boxplots
(p28 in culture A1 and p25 in culture A2)
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H and CCSER2 were suitable reference genes as they
were both constantly ranked in top three in NormFinder
(Fig. 3a), BestKeeper (Fig. 6a), Comparative ΔCt (Supple-
mentary Table S4, see Additional file 1) and RefFinder
(Supplementary Table S5, see Additional file 1). Further-
more, CCSER2 had no significant relative mean expression
change over successive passages (Fig. 2c) while GAPDH
had shown the least CV% (Table 2) in culture A1. Also,
the Pearson Correlation between GAPDH-CCSER2 (r =
0.515) was significant (P = 0.004), thereby indicating their
positive correlation (Fig. 7a) and corroborating their selec-
tion. Based on a similar approach, for culture A2, GAPDH
and RNA28S were selected as suitable reference genes.
Interestingly, to avoid excluding a potential candidate as a
reference gene, as a result of the strict selection of only
two reference genes, as suggested by geNorm (Fig. 5) an
experimental candidate with consistent high rankings in
all the algorithms for both cultures was also chosen.
PCBP1 was identified as a strong contender and hence
was included in the validation of selected reference genes.
PCBP1 was one of two genes to have no significant rela-
tive expression changes in culture A1 (Fig. 2e) and
claimed the top spot in NormFinder (Fig. 3), BestKeeper
(Fig. 6), Comparative ΔCt (Supplementary Table S4) and
RefFinder (Supplementary Table S5). It also consistently
ranked in the top five genes as per the geNorm analysis
for both cultures (Fig. 4a and b).
Generation of data for two genes of interest (GOIs) &
validation of reference genes using normalization
To further evaluate the four selected reference genes
(GAPDH, RNA28S, CCSER2 and PCBP1) and their utility
as reference genes, two simulated datasets were created.
The genes simulated were referred to as Gene of Interests
(GOI) 1 and 2. Both were assigned some random Cq
values (triplicates for 3 lysates over 4 passages for cul-
ture A1 and over 5 passages for culture A2). The criteria
for the assignment of Cq values, as well as the datasets
Fig. 2 Relative change of expression of the candidate genes (a) RNA18S (b) PUM1 (c) CCSER2 (d) HNRNPL (e) PCBP1 and (f) SF3A1 over successive
passages in both cultures A1 and A2. The expression change was measured as 2-Cq with the experimental calibrators marked as gray boxplots
(p28 in culture A1 and p25 in culture A2)
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are presented in Supplementary Table S6 and S7 (see
Additional file 1).
For GOI 1 in culture A1, as suggested by the algorithms
used in this study, the GAPDH – CCSER2 pair proved its
utility when used for normalization of the simulated
GOI 1 (Supplementary Fig. S1A, see Additional file 2
and Fig. 8a). After normalization with two other pairs,
namely GAPDH – PCBP1 and CCSER2 – PCBP1,
there were no statistically significant fold changes
(ANOVA P > 0.05), in culture A1, GOI 1, as seen in
Fig. 8a (also see Supplementary Fig. S1A, Additional
file 2). In culture A2, the most stable pair suggested
was GAPDH-RNA28S, which when used for
normalization of GOI 1 showed statistically significant
fold changes (ANOVA P < 0.05) for passage 25/28 and
passage 25/30. Furthermore, all other reference genes
pairs in culture A2 showed statistically significant fold
changes when used for normalization (Supplementary
Fig. S1B, see Additional file 2 and Fig. 8b).
Normalization was then performed in pairs of three
reference genes to investigate whether any pairing can
be used for normalization, as shown in Supplementary
Table S8 (see Additional file 1) and Fig. 8c. In culture
A1, all the different combinations of reference genes
possible showed successful normalization while in cul-
ture A2, only GAPDH-PCBP1-CCSER2 triplet achieved
Fig. 3 NormFinder analysis for both cultures (a) A1 and (b) A2 shown as group standard deviations (S.D)
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successful normalization (Fig. 8d and Supplementary
Table S8, Additional file 1).
On similar lines, for GOI 2 in culture A1, GAPDH –
CCSER2 pair produced statistically significant results in
fold change (ANOVA P = 0.035) after normalization of
GOI 2, indicating the pair may not after all be able to
handle large differences in Cq values (greater than +/ 0.5
Cq) as seen in Fig. 8a and Supplementary Fig. S2A (see
Additional file 2). Interestingly, all the other reference
gene pairs proved their utility and produced insignificant
changes (ANOVA P > 0.05) after normalization of GOI 2
in culture A1 (Fig. 8a and Supplementary Fig. S2A, see
Additional file 2). In this instance, for culture A2, GAPD
H-RNA28S pair produced statistically significant fold
changes (ANOVA P = 0.07), indicating it not to be a suit-
able pair for normalization. For all pairs in culture A2,
statistically significant changes were recorded in only
one passage, p25/p29, as seen in Fig. 8b (also see Supple-
mentary Fig. S2B, Additional file 2), and hence further
normalization with three reference genes was under-
taken in a bid for successful normalization.
After performing further normalization of GOI 2 for
cultures A1 and A2 in pairs of three reference genes
(Supplementary Table S9, see Additional file 1), our ana-
lysis showed no suitable pair of reference genes for GOI
2 in culture A2 (Fig. 8d) but for culture A1, GAPDH-
Fig. 4 geNorm analysis of the selected candidate genes in both cultures (a) A1 and (b) A2 indicated as M values (stability values) on the Y-axis
and genes on the X-axis. The lower the stability value, the more stable the gene and vice-versa. M value of less than 1 is considered appropriate
for candidature as reference gene. 18S and 28S refers to RNA18S and RNA28S respectively
Fig. 5 Determination of optimal number of reference genes needed for normalization (geNorm) for both cultures using pairwise Vn/n + 1 analysis.
The recommended cutoff is the lowest Vn/n + 1 below the threshold of 0.15. In the present study, both the cultures had V2/3 less than 0.15,
indicating addition of a third reference gene would not affect normalization results
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PCBP1-CCSER2 was the only triplet to yield successful
normalization (Fig. 8c).
Validation of selected reference genes with normalization
of qPCR data
To support and continue perusing the selected reference
gene pairs, two genes of interest were also used, namely
AURKA (Aurora Kinase A) and KRT19 (Keratin 19). The
qPCR was performed, and the dataset was normalized
using the reference gene pairs as shown in Supplemen-
tary Fig. S3-S4 (see Additional file 2). Statistical signifi-
cance and methodology were the same as for GOI 1 and
GOI 2. The Cq range for AURKA was from 23.36 (min)
to 24.51 (max) with mean Cq of 23.92 ± 0.39 for culture
A1 while for culture A2, the Cq range was from 23.19
(min) to 24.32 (max) with mean Cq of 23.74 ± 0.31. The
Cq range for KRT19 was from 18.90 (min) to 20.13
(max) with mean Cq of 19.29 ± 0.29 for culture A1 while
for culture A2, the Cq range was from 18.65 (min) to
21.19 (max) with mean Cq of 19.96 ± 0.77.
Upon normalization of AURKA, none of the gene pairs
in culture A1 were able to normalize AURKA adequately
(P < 0.05) as seen in Fig. 8a and Supplementary Fig. S3A
(see Additional file 2). In culture A2, however, four ref-
erence gene pairs were able to normalize the AURKA
(Fig. 8b; Supplementary Fig. S3B, see Additional file 2).
For KRT19, in both cultures A1 and A2, no gene pair
could yield successful normalization (Fig. 8a and b;
Fig. 6 BestKeeper results for standard deviation with crossing points (S.D ± C.P) on the Y axis with the selected candidate genes on the X-axis for
(a) culture A1 and (b) culture A2. The most stable genes are considered to have a S.D as close as possible to 1 with not greater than 1. 18S rRNA
and 28S rRNA refers to RNA18S and RNA28S respectively
Fig. 7 Pearson correlation of the pairwise gene expression stability as obtained from BestKeeper algorithm. The correlation was assessed for all
candidate genes in both (a) culture A1 and (b) culture A2. The darker the blue, the higher the positive correlation between the genes as seen in
the legend. 18S and 28S refers to RNA18S and RNA28S respectively
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Supplementary Fig. S4A and S4B, see Additional file 2).
Again, further investigations were done using genes in
triplets.
For AURKA, in culture A1, GAPDH-PCBP1-CCSER2
and GAPDH-CCSER2-RNA28S yielded successful
normalization (Fig. 8c and Supplementary Table S10, see
Additional file 1). In culture A2, GAPDH-PCBP1-CCSE
R2 and PCBP1-CCSER2-RNA28S pairs showed adequate
normalization of AURKA (Fig. 8d and Supplementary
Table S10, see Additional file 1). For KRT19, in both cul-
tures A1 and A2, only GAPDH-PCBP1-CCSER2 triplet
showed successful normalization (Fig. 8c and d; Supple-
mentary Table S11, see Additional file 1).
Combined analysis of Dataset from MCF-7 sub-clones A1
and A2: analysis of MCF-7 cell line
From the extensive analysis provided above, the bio-
logical replicate cultures of MCF-7 (sub-clones) does not
necessarily depict similar phenotypic characteristics and
gene expression and hence, the reproducibility of the re-
sults among sub-clones may not be 100% efficient.
Therefore, to further investigate the reference gene/s
which show least variance overall in the MCF-7 cell line,
the dataset from both sub-clones A1 and A2 were com-
bined and analyzed. CV% was determined to evaluate
the stability of reference genes (Table 3). As before,
comprehensive analysis was conducted for the combined
dataset using NormFinder, geNorm, BestKeeper, Com-
parative ΔCt and RefFinder. The gene rankings were de-
termined using each of these algorithms as summarized
in Table 3.
As reported in Table 3, CV% analysis revealed that the
least variable gene is PCBP1 (CV% = 22.13%) closely
followed by ACTB and RNA28S (CV% = 22.28 and
22.74% respectively). NormFinder, Comparative ΔCt and
RefFinder had almost identical rankings where GAPDH
and PCBP1 were consistently reported as the most stable
genes. Furthermore, in Comparative ΔCt and RefFinder,
both CCSER2 and RNA28S were shown to be the next
most stable genes. In contrast, NormFinder ranked
RNA28S before CCSER2, however both were reported in
top four genes. geNorm on the other hand ranked CCSE
R2 – PCBP1 duo as the most stable genes (M value =
0.23). It further ranked GAPDH as the third most stable
gene. geNorm was further used to calculate Vn/Vn + 1 to
estimate the number of reference genes required for
normalization of GOIs. geNorm reported that two refer-
ence genes should be used (V2/3 = 0.005 is less than the
cutoff of 0.15). BestKeeper, however ranked RNA28S
and PUM1 as the two most stable genes whilst ranking
PCBP1 as the fourth most stable gene.
Finally, BestKeeper was used to report the Pearson’s
correlation (r) among genes. A high positive correlation
was reported for PCBP1-CCSER (r = 0.757). A moderate
Fig. 8 Summary of Normalization of GOI 1, GOI 2, AURKA and KRT19 by different recommended reference genes pairs. Green circles indicate
successful normalization of the gene of interest by respective reference gene pair (a) Normalization of the four genes of interest by selected
reference genes in pairs of 2 in culture A1 (b) Normalization of the four genes of interest by selected reference genes in pairs of 2 in culture A2
(c) Normalization of the four genes of interest by selected reference genes in pairs of 3 in culture A1. (d) Normalization of the four genes of
interest by selected reference genes in pairs of 3 in culture A2. Blue box indicates normalization by GAPDH-CCSER2 pair (recommended pair in
culture A1) while Pink box indicates normalization by GAPDH-RNA28S pair (recommended pair in culture A2). Red box indicates the best reference
gene triplet (GAPDH-CCSER2-PCBP1)
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positive correlation was reported for PCBP1-GAPDH
and CCSER-GAPDH pairs (r = 0.643 and 0.666 respect-
ively). Whilst RNA28S showed moderate positive correl-
ation with GAPDH (r = 0.623) and PCBP1 (r = 0.686), it
portrayed a low positive correlation with CCSER2 (r =
0.496). Two genes that were constantly ranked as the
least stable (most variable) were RNA18S and RPL13A
except by CV% and BestKeeper.
Transcriptomic analysis of the reference genes from TCGA
database
The TCGA (The Cancer Genome Atlas) database was
used for transcriptomic validation of the expression of
the reference genes analysed in the study. Based on the
PAM50 BRCA subtype classifications, data of only Lu-
minal A subtype tumor patients were analysed (others
like Normal, Luminal B, Undertermined, Basal etc. sub-
types were removed). In the dataset, selected reference
genes were looked for. Normalised gene expression data
was available for 9 of the 12 reference genes (data not
available for ACTB, RNA18S and RNA28S) as presented
in Supplementary Table S12 (see Additional file 1). For
better data visualization and understanding gene expres-
sion of the reference genes, the “normalized_count” was
converted to the log scale using log2 (normalized_count
+ 1) as presented in Supplementary Fig. S5 (see Add-
itional file 2). CCSER2 is the most stable gene (from our
selected reference genes) identified in the database for
Luminal A sub-type breast cancer. Furthermore, PCBP1
was found to be quite stably expressed. Interestingly,
GAPDH which was identified as the most stable gene in
both cultures, was identified as the least stable gene in
the transcriptomic analysis.
To evaluate the TPM (transcripts per million), the
TCGAbiolinks was used again to retrieve the clinical,
morphological and expression data of Luminal A sub-
type breast cancer patients. In case of TPM, the data
was available for 10 of the 12 selected candidate
Table 3 Comprehensive analysis of candidate reference gene ranking with dataset from both culture A1 and A2 combined
CV% NormFinder geNorm
Candidate Gene CV% Rank Candidate Gene Group S.D Rank Candidate Gene Stability value M Rank
PCBP1 22.13 1 GAPDH 0.15 1 CCSER2 0.23 1
ACTB 22.28 2 PCBP1 0.16 2 PCBP1 0.23 1
RNA28S 22.74 3 RNA28S 0.21 3 GAPDH 0.25 2
PUM1 22.99 4 CCSER2 0.21 3 ACTB 0.26 3
CCSER2 23.17 5 ACTB 0.21 3 HSPCB 0.28 4
GAPDH 23.62 6 HSPCB 0.24 4 RNA28S 0.29 5
SF3A1 26.49 7 PGK1 0.27 5 PGK1 0.30 6
RNA18S 27.97 8 HNRNPL 0.28 6 HNRNPL 0.31 7
RPL13A 28.11 9 PUM1 0.29 7 SF3A1 0.32 8
HSPCB 28.65 10 RPL13A 0.29 7 PUM1 0.33 9
HNRNPL 35.10 11 RNA18S 0.30 8 RPL13A 0.34 10
PGK1 35.61 12 SF3A1 0.30 8 RNA18S 0.35 11
BestKeeper Comparative ΔCt RefFinder
Candidate Gene S.D Rank Candidate Gene Average S.D Rank Candidate Gene Geomean Rank
RNA28S 0.25 1 GAPDH 0.30 1 GAPDH 1.97 1
PUM1 0.26 2 PCBP1 0.30 1 PCBP1 2.00 2
ACTB 0.26 3 CCSER2 0.33 2 CCSER2 2.91 3
PCBP1 0.27 4 RNA28S 0.33 2 RNA28S 2.91 3
GAPDH 0.27 4 ACTB 0.33 2 ACTB 4.16 4
CCSER2 0.28 5 HSPCB 0.34 3 PUM1 6.34 5
SF3A1 0.32 6 PGK1 0.36 4 HSPCB 6.51 6
RPL13A 0.33 7 HNRNPL 0.37 5 PGK1 7.84 7
RNA18S 0.34 8 PUM1 0.38 6 HNRNPL 8.85 8
HSPCB 0.35 9 SF3A1 0.38 6 SF3A1 9.32 9
PGK1 0.41 10 RPL13A 0.38 6 RPL13A 9.92 10
HNRNPL 0.43 11 RNA18S 0.38 6 RNA18S 10.93 11
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reference genes (except for RNA28S and RNA18S) as
shown in Supplementary Table S13 (see Additional file 1).
For better visualization and data analysis, the TPM values
were also converted to logarithmic scale using log2(TPM).
All the selected reference genes from the database
showed low variance with a S.D. (log2 TPM) of less than
1. Also, they all showed medium to high expression level
since the mean (log2 TPM) was greater than 5 for all
genes (except for CCSER2, which showed lower expres-
sion levels). The log2 (TPM) ranges of all the genes are
shown in Supplementary Fig. S6 (see Additional file 2).
Relationship between Cq values from RT-qPCR and log2
(TPM) of TCGA RNA-Seq
To facilitate an estimation of the relationship between
the Cq values obtained from RT-qPCR for both cultures
A1 and A2 and the log2 (TPM) values obtained from
TCGA database, a correlation analysis was performed, as
seen in Supplementary Fig. S7 (see Additional file 2). Al-
though there exists no formal relationship or formula
between Cq and Log2 (TPM), the formulas (y intercept
and R2) presented in Supplementary Fig. S7, provide an
estimation of the Ct for each reference gene prior to
RT-qPCR experiments based on RNA-Seq data of Lu-
minal A sub-type breast cancer which may be extended
to other Luminal A cell lines. Pearson’s correlation was
also calculated between Cq values from both cultures A1
and A2 (and combined mentioned as MCF-7) and log2
(TPM) as seen in Table 4. Statistical significance was set
at P < 0.05. No significant correlation was found in any
of the gene in both cultures when Cq values were com-
pared with Log2 (TPM) RNA-Seq values.
Nutrient stress – fold changes of reference genes
To demonstrate and validate the reference gene triplet
(GAPDH-CCSER2-PCBP1), samples from MCF-7 cells
cultured in four different culturing conditions were ana-
lyzed. The cell cultures were named as B5, D5, E5 and
R5. We first calculated the fold change in expression of
reference genes in control (cultures A1 and A2) versus
nutrient stress (cultures B5, D5, E5 and R5). Addition-
ally, we examined the potential differences in fold
change between control cultures. We selected p28 from
culture A1 and p25 from culture A2 for comparisons of
fold change as shown in Supplementary Table S14 (see
Additional file 1). A well defined threshold for accept-
able range of tolerable fold change does not exist, how-
ever, a commonly suggested arbitary limit of ≥ 2x fold
change was used in the present study to decide whether
or not the reference gene was a good internal con-
trol [38]. Accordingly, our analysis revealed that there
was more than 2x fold change for ACTB (all nutrient
stress cultures), PGK1 (B5, D5 and E5), GAPDH (E5)
and HNRNPL (E5) when compared with control MCF-7
cell line (A1 + A2).
Nutrient stress – expression differences of GOIs when
normalized using GAPDH-CCSER2-PCBP1
Finally, the normalized fold change in expression for
AURKA and KRT19 was evaluated in all four nutrient
stress cultures and normalized against 3 controls – p28
from culture A1, p25 from culture A2 and p25 with p28
for overall MCF-7 cell line as shown in Fig. 9. The triplet
successfully normalized the expression fold change for
both genes of interest in all stress cultures except for
B5/p28 (culture A1), where, although the fold change
was < 2, it was found to be statistically significant (P =
0.045). Fold change due to nutrient stress varied from −
0.593 (D5 and E5) to − 1.533 (B5) for AURKA and from
− 1.292 (R5) to − 1.615 (D5) for KRT19.
Discussion
The human breast adenocarcinoma cell line, MCF-7 has
been a standard model among researchers for about five
decades, serving as a laboratory tool for in vitro studies
as well as a model for investigation of key cancer driven
Table 4 Pearson’s Correlation between Cq values from culture A1 and A2 from RT-qPCR and log2 (TPM)
Candidate Reference Gene Pearson Correlation r
(Culture A1 vs log2 TPM)
Pearson Correlation r
(Culture A2 vs log2 TPM)
Pearson Correlation r
(MCF-7 vs log2 TPM)
ACTB 0.215 (P = 0.253) - 0.028 (P = 0.852) 0.115 (P = 0.323)
GAPDH - 0.316 (P = 0.088) - 0.315 (P = 0.837) 0.078 (P = 0.504)
RPL13A - 0.018 (P = 0.923) - 0.132 (P = 0.385) - 0.071 (P = 0.272)
PGK1 - 0.308 (P = 0.097) 0.002 (P = 0.988) 0.028 (P = 0.812)
HSPCB - 0.053 (P = 0.780) - 0.013 (P = 0.927) - 0.004 (P = 0.970)
PUM1 0.229 (P = 0.221) 0.119 (P = 0.432) 0.083 (P = 0.478)
CCSER2 - 0.015 (P = 0.936) - 0.049 (P = 0.747) - 0.029 (P = 0.798)
HNRNPL - 0.150 (P = 0.428) 0.079 (P = 0.601) 0.069 (P = 0.554)
PCBP1 0.061 (P = 0.745) - 0.126 (P = 0.407) - 0.045 (P = 0.702)
SF3A1 0.310 (P = 0.095) 0.261 (P = 0.082) 0.132 (P = 0.256)
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processes that directly impact patient care and treatment
plan [39]. Despite publication of extensive evidence [9–15],
the genetic and phenotypic variance in MCF-7 sub-clones
and subpopulations is often not accounted for in the la-
boratory protocols and is hence overlooked. The main
reason for this oversight usually stems from assump-
tions that by using cells obtained from same batch
and same cell bank and by standardizing protocols
and limiting the number of passages, laboratories can
ensure that their sub-clones will “behave” with suffi-
cient stability and reproducibility [16].
Furthermore, laboratories can argue that by adher-
ing strictly to the recommendations from Good Cell
Culture Practice (GCCP) [40] and employing SNP/
STR cell authentication techniques, one can repro-
duce their results with MCF-7 sub-clones. However,
this may not be specifically related to the MCF-7
cells. In fact, MCF-7 estrogen disruptor assay failed
to get international validation in 2016 by US NICE
ATM (US National Toxicology Program Interagency
Center for the Evaluation of Alternative Toxicological
Methods). The main reason cited for failure was
Fig. 9 Normalized fold change in expression of genes of interest (a) AURKA and (b) KRT19 in stress cultures (B5, D5, E5 and R5) when compared
with control cultures (A1 and A2). Pink boxes indicate normalized fold change in expression when compared with p28 (culture A1); Blue boxes
indicate normalized fold change in expression when compared with p25 (culture A2) and Green boxes indicate normalized fold change in
expression when compared with control MCF-7 cell line (p28 + p25 from A1 and A2). * Indicates significant fold change (P < 0.005) as calculated
using Mann-Whitney U test
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centered on concerns regarding the inter-laboratory
reproducibility of results [41].
The accuracy in reproducibility of results with MCF-7
cells has been questioned previously [42], but no substan-
tial proof that dealt with variations in reference gene ex-
pression tendencies was reported. The present study
addresses this issue for the first time and reports evidence
of a heterogenous reference gene expression in sub-clones
of MCF-7 cell line which are cultured identically. There-
fore, it is pivotal to validate and test the reference genes
before their use amongst the sub-clones in order to avoid
inaccurate normalization of genes of interest.
Our analysis revealed that among the two biological rep-
licate cultures (sub-clones), there are stark differences in
the expression patterns and tendencies of the endogenous
reference genes. GAPDH- CCSER2 were identified as po-
tential genes for culture A1, while GAPDH-RNA28S were
identified for culture A2 using various algorithms. How-
ever, when they were employed for cross-normalization of
genes of interests in both cultures, both gene pairs were
unable to provide adequate results (Fig. 8). The addition
of a third gene PCBP1 to GAPDH-CCSER2 pair helped to
yield successful normalization for all 4 genes of interest
and in both cultures A1 and A2 (except for GOI 2 in Cul-
ture A2; this can be attributed most likely to limitation of
GOI 2 as being a simulated gene).
The TCGA (The Cancer Genome Atlas Program) repre-
sents a joint venture of National Cancer Institute (NCI)
and National Human Genome Research Institute (NGGR
I) which began in 2006 as a pilot project with three cancer
types (lung, ovarian and glioblastoma). This was later ex-
panded to present 33 tumor types encompassing a com-
prehensive dataset describing the molecular changes that
occur in cancer [43]. Two different approaches were
employed to analyze the legacy dataset and compare the
gene expression, namely normalized_count (file extension
rsem.genes.normalized_results) and TPM obtained from
scaled_estimate (file extension rsem.genes.results). Both
approaches revealed CCSER2 to be the most stably
expressed. The CV% was estimated at 17.49% from TCGA
analysis which was between the range of 15.55% (culture
A1) and 25.65% (culture A2) obtained from RT-qPCR
(Table 2) in present study. PCBP1 was also expressed
quite stably with CV% estimated at 3.96% from TCGA
analysis. The RT-qPCR range for PCBP1 obtained was
from 14.89% (culture A1) and 24.90% (culture A2). Finally,
CV% for GAPDH from TCGA was 6.44% while RT-qPCR
Cq values ranged from 12.35% (culture A1) to 26.84%
(culture A2) (Table 2).
Whilst TCGA analysis of CCSER2 and PCBP1 sup-
ported our findings in the present study and bolsters
their selection, contrastingly GAPDH was revealed to be
unstably expressed. It is important to point out that the
difference in results could be attributed to various
underlying limitations. Firstly, TCGA requires all malig-
nancies in its database to be primary, untreated tumors
(except cutaneous melanoma) [44]. Furthermore, all
specimens deposited were garnered from available frozen
materials, from different institutes, thereby introducing
bias in institutional biorepository collections, stemming
from institutional research interests, operative protocols,
or patient populations [44]. In addition, metastatic dis-
eases or aggressive primary tumors are usually subject to
neoadjuvant therapies which make their inclusion in
TCGA database difficult because of limited availability of
untreated specimens [44]. However, all these limitations
should not diminish the fact that TCGA remains one of
the richest source of clinical and research importance, es-
pecially in developing an integrated picture of commonal-
ities, differences, and emergent themes across tumors.
Use of GAPDH as reference gene in qPCR normalization
has been a matter of controversy in its own right. GAPDH
has been shown to have increased expression in cancers
from other body regions specially from cervix, prostate, pan-
creas and lungs [45–48]. Furthermore, it has been reported
that GAPDH is overexpressed in MCF-7 cells treated with
estradiol [49]. Hence, many studies suggest not to use GAPD
H as a control gene to study breast cancer or they rank
GAPDH as the least stable gene [25, 32, 33, 49–51]. As re-
ported by Liu et al. [25], almost half of the publications in
PubMed database used GAPDH as a single reference gene
for normalization of gene expression analyses with RT-
qPCR. Even with the contradiction regarding consideration
of GAPDH as a suitable or non-suitable candidate, attention
should be paid to its selection based on the experimental
conditions and study design [33].
CCSER2 is described as a “novel housekeeping gene”
(nHKG) by Tilli et al. [27], who provided evidence of its
use as a reference gene in breast cancer studies. They
demonstrated that expression of CCSER2 is expected to
be like the other nHKGs they had identified that could
increase the assessment consistency of normalization.
Correspondingly, CCSER2 was ranked highly in culture
A1 in our analysis and was confirmed by transcriptomic
validation to be the least variable in expression, therefore
it can be hence, used for future analysis and experi-
ments. In addition, PCBP1, the most trustworthy gene in
our analysis with a stable ranking across all platforms
shows promising candidature as an endogenous refer-
ence gene as reported also by Jo et al. [28].
Another gene that came to light in the analysis for cul-
ture A2 was RNA28S. The gene has not been reported
much in the context for MCF-7 cell line and was added
as an in-house suggestion in the present study. However,
drawbacks to the use of RNA18S or RNA28S as refer-
ence genes have been reported such as an absence of
purified mRNA samples and their high abundance com-
pared to target mRNA transcripts making it difficult to
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accurately subtract the baseline value in RT-PCR data
analysis [20]. Furthermore, the use of these genes as
control genes is not suggested due to the imbalance be-
tween mRNA and rRNA fractions in these molecules
[52]. In addition, it has also been shown that certain
drugs and biological factors may also affect the rRNA
transcription [53, 54].
ACTB, another widely used reference gene, has also
been previously verified as a candidate stable reference
gene for breast cancer tissue and normal tissues [32, 55].
ACTB and HSPCB were the best reference genes identi-
fied by Liu et al. [25] for ER+ breast cancer cell lines in-
cluding MCF-7. They further reported that RNA18S and
ACTB were the best pair of genes across all breast can-
cer cell lines [25]. Despite the widespread acceptance of
ACTB for normalization among a set of human breast
cancer cell lines of increasing metastatic potential, limi-
tations have been reported as well [29]. Jacob et al. [33]
identified HSPCB as one of the suitable genes across a
variety of cancer cell lines including MCF-7. Our ana-
lysis revealed contrasting results. ACTB, HSPCB,
RPL13A and RNA18S were ranked outside of the top
three in both cultures. Furthermore, ACTB and HSPCB
reported high CV% and showed significant fold changes
(2-Cq analysis). The difference between our results and
previously reported studies is suggestive of the fact that
inter-laboratory replication of results with MCF-7 cell
line is not very accurate.
Nonetheless, the authors caution the readers that the
results obtained in the present study must be seen in the
light of some limitations. Firstly, the reference genes
were validated for their expression and utility in in-vitro
only and hence further validation is needed to replicate
our findings in-vivo, like MCF-7 derived xenograft
models. Secondly, the present study tested reference
genes in four different nutrient stress conditions, how-
ever, other conditions like hypoxia, drug treatment etc.
still need to be tested to validate the stability of GAPD
H-CCSER2-PCBP1 triplet. Finally, given the heterogen-
eity of the MCF-7 cell line, it remains to be tested if the
results from our study could be replicated in MCF-7 cell
line that has been obtained from a different batch num-
ber or source i.e. inter-laboratory validation of the re-
sults is still needed.
An interesting observation was made regarding pas-
sage p28 from culture A2 (Figs. 1 and 2). Lower Cq
values were obtained for all housekeeping genes when
compared to other passages in the same culture. A
plausible explanation for this observation cannot be pro-
vided at this point. Good Cell Culturing Practices
(GCCP) were strictly adhered to and the cell culturing,
RNA isolation, quality control using PCR and RT-PCR
were all performed by the same single operator to
minimize technical errors. Furthermore, the RNA
isolation for all passages (and all lysates) for both the
cultures was executed in a single batch, on the same day.
The same was also true for RT-PCR, thereby effectively
minimizing any chance of human error.
A more detailed discussion of the results obtained, and
their implications is presented in Additional file 3. The
study, together with its results, aims to provide the
readers and researchers an evidence-based recommenda-
tion of the most suitable reference genes in routinely
cultured MCF-7 cell line with extensive research and in-
vestigations. Furthermore, we report the possible exist-
ence of a heterogenous differential behavior of
endogenous reference genes within the sub-clones of the
MCF-7 cell line. The authors suggest that more detailed
and diverse studies should be undertaken to explore
more about the differential expression of the endogen-
ous reference genes. Future studies could be aimed at in-
vestigating the reference gene expression amongst other
sub-populations of MCF-7 and amongst other breast
cancer cell lines.
Lastly, given the widespread use of cancer cell lines
not only for basic research but also for drug develop-
ment and regulatory decision making, ensuring that sub-
clones among the cell line are adequately standardized
in their expression behavior tends to represent a challen-
ging path forward [16]. A strategy outlined by Tilli et al.
[27], whereby experiments are normalized with a panel
of reference genes whose expressions have been proven
to be as minimally variable as possible and as robust as
possible under varying conditions gains our support as
well. Although geNorm recommended to use two refer-
ence genes, we would recommend that three reference
genes should be employed to better overcome and han-
dle any reference gene expression variability in the sam-
ples that may be present in the sub-clones. Triplet of
GAPDH-CCSER2-PCBP1 should provide a potential al-
ternative to traditionally used reference genes for refer-
ence gene matrix in MCF-7 cells. We are optimistic that
MCF-7 cell line will continue to contribute eminently
towards improved and novel treatment modalities for
breast cancer patients.
Conclusions
Genetic and phenotypic heterogeneity showcased by
MCF-7 cell line poses a conundrum with some un-
answered questions. Performing reference gene analysis
may not be feasible for every sub-clone and hence, based
on our results and extensive validation, we suggest using
GAPDH-CCSER2-PCBP1 triplet for normalization of
genes of interest in MCF-7 cell line whilst keeping in
mind the limitations of the present study. Furthermore,
we suggest avoiding the use of ACTB, GAPDH and
PGK1 as single internal controls.
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Methods
Culture and seeding conditions of MCF-7 biological
replicate cultures (sub-clones A1 and A2)
Samples were collected from MCF-7 cell line (ATCC,
HTB-22) that has been used in our laboratory for previ-
ous studies [56]. Samples from different passages were
cryopreserved during culturing at different time points.
Frozen stocks were taken from MCF-7 cells grown in
culturing conditions as described below. For this study,
two aliquots from samples that were previously cryopre-
served were thawed at the same time. Culture A1 was
cryopreserved after passage 27 (p27) and culture A2 was
cryopreserved after passage 24 (p24). They were then
cultured in the same conditions simultaneously over
multiple successive passages. From each culture, three
samples were collected from each passage. Culture A1
was cultured from passage 28 (p28) till passage 32 (p32)
while culture A2 was cultured from passage 25 (p25) till
passage 30 (p30). Cells were cultured in Dulbecco Modi-
fied Eagle’s medium with Ham’s F12 nutrient supple-
ment DMEM/F12 (1:1) with 10% FBS (fetal bovine
serum), supplemented with 1% penicillin/streptomycin
(Thermo Fisher Scientific) in 37 °C, 5% CO2 and the
growth medium was replaced every 2–3 days. Cell passa-
ging was performed using 1x TrypLE solution (Thermo
Fisher Scientific). Cells were grown to 80–100% conflu-
ence in T-25 cm2 flasks. Cell count and viability was esti-
mated using a cell counting chamber (Improved
Neubauer Hemocytometer). For further consecutive pas-
sages, cells were seeded at a density of 5000 cells/cm2.
Triplicates (3 lysates/samples) of 1 × 106 cells each from
each passage from both cultures were taken for isolation
of total RNA.
Culturing conditions of MCF-7 cultures in nutrient stress
The MCF-7 samples from previous study in our labora-
tory [56] were used to validate the reference gene triplet
in cells undergoing different nutrient conditions, i.e. cul-
tured in different media. Two lysates from our cryobank
were used for RNA extraction and further analysis. Cul-
ture B5 was cultured in Medium 199 (M199) with 5%
FBS; culture D5 in DMEM/F12 (1:3) with 5% FBS; cul-
ture E5 in DMEM/F12 (1:1) with 5% FBS and culture
R5 in Roswell Park Memorial Institute (RPMI) 1640
with 5% FBS. A detailed description of growth media
composition is presented in Additional file 6. Similar to
cultures A1 and A2, these cultures were also grown in
37 °C, 5% CO2 with growth media replaced every 2–3
days. Identical protocol was followed for cell count and
viability as described in previous section.
RNA extraction and cDNA synthesis
Total RNA was extracted using Trizol reagent (Thermo
Fisher Scientific) according to the manufacturer’s
protocol. The concentration and quality of the RNA was
assessed by Nanodrop 2000 with the mean absorption
ratios A260/280 and A260/230 checked to ensure RNA
purity. RNA integrity was checked using 1.8% agarose
gel electrophoresis. The RNA was further examined for
DNA contamination by PCR for ACTB and GAPDH.
The PCR reaction was performed in the presence of
both positive and negative controls. No amplified PCR
product was found on the agarose gel after PCR and
electrophoresis of the RNA samples (except for positive
controls). The cDNA synthesis reaction was carried out
using the High Capacity cDNA Reverse transcription kit
(Thermo Fisher Scientific), in accordance with the man-
ufacturer’s protocol and guidelines and was stored at −
20 °C until further analysis.
Selection of candidate reference gene and primer design
In total, 12 candidate housekeeping genes were selected
by perusing relevant literature related to breast cancer
and/or MCF-7 cell line and literature that reported tran-
scriptomic data based on TCGA (The Cancer Genome
Atlas) database [25–28, 33–37]. All selected genes are
shown in Additional file 4. The selected genes have been
time and again reported as suitable internal controls or
have been described with controversial findings. The
studies span over almost two decades from 2000 to 2019
and have never been collectively investigated in MCF-7
cell line. Hence, the present study took these findings
from previous studies into account while selecting the
genes.
The sources of gene primers and primer sequence used
for the reference genes are shown in Additional file 4. The
present study employed the primers that were reported
before in the literature to maintain inter-reliability and
inter-connectivity with the previous studies. Primers for
RNA28S and PGK1 were designed using Primer3Plus [57].
The melting curves of all selected gene primers are pre-
sented in Additional file 4. The primer sequences (de-
signed using Primer3Plus) for genes of interest, AURKA
and KRT19 are also presented in Additional file 4.
Real time quantitative PCR (RT-qPCR)
Real time quantitative PCR (qPCR) was performed using
10 ng of cDNA per reaction on ViiA 7 RT-PCR thermo-
cycler (Thermo Fisher Scientific). Triplicate reactions of
each sample were performed using HOT FIREPol Eva-
Green qPCR Supermix (Solis Biodyne) on 384 well
plates (Thermo Fisher Scientific). The cycling parame-
ters were: 95 °C for 4 mins followed by 40 cycles of amp-
lification at 95 °C for 30 s and 58 °C for 20 s followed by
72 °C for 30 s with melting curve. All assays were per-
formed with a non-template control (NTC).
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Algorithms and statistical analysis
A detailed description of criteria and methodology with
suitable illustrations and examples is shown in Add-
itional file 5. Statistical significance was set at P < 0.05
(unless otherwise stated) and was calculated using Ana-
lysis of Variance (one-way ordinary ANOVA (with rele-
vant multiple comparisons test and corrections) where
data was distributed normally. For non-normally distrib-
uted data (checked using Shapiro-Wilk test), the non-
parametric ANOVA (Kruskal-Wallis ANOVA) with re-
spective corrections and multiple comparisons was used.
The comparisons were made to compare the gene ex-
pression at successive passages to the gene expression at
the smallest passage number. Data Management and
storage along with descriptive statistics were done using
MS Excel (Microsoft Office 365). The statistical analysis
was done using JASP (Jeffery’s Amazing Statistical Pro-
gram) v.0.10.2.0 and R Studio v3.6.3.
TCGA Transcriptomic bioinformatics
The R based package < TCGAbiolinks > [58–60] was used
to retrieve the TCGA gene expression data. The TCGA leg-
acy archive was accessed for open access patient data. The
legacy archive has unmodified copy of data that was previ-
ously stored in CGhub and TCGA data portal and uses
GRCh37 (hg 19) as references. After downloading and pre-
paring the data (GDCdownload and GDCprepare function),
the data was exported to Excel for further analysis.
Supplementary information
Supplementary information accompanies this paper at https://doi.org/10.
1186/s12860-020-00313-x.
Additional file 1: Supplementary Tables.
Additional file 2: Supplementary Figures.
Additional file 3: Extended Discussion.
Additional file 4: Primer Design & Sequence.
Additional file 5: Calculations & Algorithms.
Additional file 6: Control & Stress Media.
Abbreviations
MCF-7: Michigan Cancer Foundation – 7; RGs: Reference genes; RT-PCR: Real
time – polymerase chain reaction; p: Passage; GOI: Gene of Interest;
CV%: Coefficient of Variation %; S.D.: Standard Deviation; TPM: Transcripts per
Million; BRCA: Breast Invasive Carcinoma; TCGA: The Cancer Genome Atlas;
HUGO: Human Genome Organisation; Lum A: Luminal A Molecular Subtype
Breast Cancer; FBS: Fetal Bovine Serum; ACTB: Actin Beta; GAPD
H: Glyceraldehyde-3-phosphate Dehydrogenase; RPL13A: Ribosomal Protein
L13a; PGK1: Phosphoglycerate Kinase 1; HSPCB: Heat Shock Protein 90 Alpha
family Class B member 1; RNA18S: RNA, 18S ribosomal; RNA28S: RNA, 28S
ribosomal; PUM1: Pumilio RNA Binding family member; CCSER2: Coiled-Coil
Serine Rich protein 2; HNRNPL: Heterogenous Nuclear Ribonucleoprotien L;
PCBP1: Poly(rC) Binding protein 1; SF3A1: Splicing factor 3a subunit 1;




IC, NJ and VP conceptualized the study while IC, DN and NJ were
responsible for methodology. Data and Statistical analysis were done by NJ.
Data curation was done by IC and NJ. Validation of the study protocol and
results was done by VP, IC and NJ. Visualization was done by NJ while
project supervision and funding acquisition was done by IC. Investigations
and validation were done by IC, DN and VP. Original draft was prepared by
NJ and IC while revisions and final editing were done by VP, DN, IC and NJ.
The authors have read and approved the final manuscript for publication.
Authors’ information
All Authors (NJ, DN, VP and IC) are affiliated with the Laboratory of Molecular
Genetics, Institute of Oncology, Riga Stradiņš University, Dzirciema street 16,
Riga, Latvia LV-1007.
Funding
The present study was funded by Riga Stradiņš University (RSU) Project
Nb.5–1/127/2019.
Availability of data and materials
The datasets generated for Genes of Interest GOI 1 and 2 are available as
Supplementary Tables S6 and S7 respectively (see Additional file 1). The
primer sequences for all genes studied in the study are available in
Additional file 4. Suitable illustrations and examples of calculations
performed in the present study are shown in Additional file 5. List of
reagents used, and their manufacturers are enlisted in Additional file 6. TCGA
dataset is available for download from TCGAbiolinks package (R studio) or
TCGA repository. Data is available from the corresponding author upon
reasonable request via email provided (inese.cakstina@rsu.lv).





The authors declare no competing interests in the present study.
Furthermore, neither funders nor the funding institution had a role in the
design of the study; in the collection, analysis, or interpretation of data; in
the writing of the manuscript, or in the decision to publish the results.
Received: 10 July 2020 Accepted: 16 September 2020
References
1. Adrian V. Lee, Steffi Oesterreich, Nancy E. Davidson, MCF-7 Cells—Changing
the Course of Breast Cancer Research and Care for 45 Years. JNCI: J Natl
Cancer Inst. 2015;107(7):djv073. https://doi.org/10.1093/jnci/djv073.
2. Goldhirsch A, Winer EP, Coates AS, Gelber RD, Piccart-Gebhart M,
Thürlimann B, Senn HJ, Panel members. Personalizing the treatment of
women with early breast cancer: highlights of the St Gallen International
Expert Consensus on the Primary Therapy of Early Breast Cancer 2013. Ann
Oncol. 2013;24(9):2206–23. https://doi.org/10.1093/annonc/mdt303.
3. Comşa Ş, Cîmpean AM, Raica M. The Story of MCF-7 Breast Cancer Cell Line:
40 years of Experience in Research. Anticancer Res. 2015;35(6):3147–54.
4. Huang SB, Chou D, Chang YH, Li KC, Chiu TK, Ventikos Y, Wu MH.
Development of a pneumatically driven active cover lid for multi-well
microplates for use in perfusion three-dimensional cell culture. Sci Rep.
2015;5:18352. https://doi.org/10.1038/srep18352.
5. Burdall SE, Hanby AM, Lansdown MR, Speirs V. Breast cancer cell lines: friend
or foe? Breast Cancer Res. 2003;5(2):89–95. https://doi.org/10.1186/bcr577.
6. Osborne CK, Hobbs K, Trent JM. Biological differences among MCF-7 human
breast cancer cell lines from different laboratories. Breast Cancer Res Treat.
1987;9(2):111–21. https://doi.org/10.1007/BF01807363.
7. Resnicoff M, Medrano EE, Podhajcer OL, Bravo AI, Bover L, Mordoh J.
Subpopulations of MCF7 cells separated by Percoll gradient centrifugation:
a model to analyze the heterogeneity of human breast cancer. Proc Natl
Acad Sci U S A. 1987;84(20):7295–9. https://doi.org/10.1073/pnas.84.20.7295.
8. Baguley BC, Leung E. In Breast Cancer Carcinogenesis, Cell Growth and
Signalling Pathways. In: Gunduz M, editor. In tech, 2011.
Jain et al. BMC Molecular and Cell Biology           (2020) 21:68 Page 17 of 19
9. Seibert K, Shafie SM, Triche TJ, Whang-Peng JJ, O'Brien SJ, Toney JH, Huff
KK, Lippman ME. Clonal variation of MCF-7 breast cancer cells in vitro and
in athymic nude mice. Cancer Res. 1983;43(5):2223–39.
10. Whang-Peng J, Lee EC, Kao-Shan CS, Seibert K, Lippman M. Cytogenetic
studies of human breast cancer lines: MCF-7 and derived variant sublines. J
Natl Cancer Inst. 1983;71(4):687–95.
11. Butler WB, Berlinski PJ, Hillman RM, Kelsey WH, Toenniges MM. Relation of
in vitro properties to tumorigenicity for a series of sublines of the human
breast cancer cell line MCF-7. Cancer Res. 1986;46(12 Pt 1):6339–48.
12. Nugoli M, Chuchana P, Vendrell J, Orsetti B, Ursule L, Nguyen C, Birnbaum
D, Douzery EJ, Cohen P, Theillet C. Genetic variability in MCF-7 sublines:
evidence of rapid genomic and RNA expression profile modifications. BMC
Cancer. 2003;3:13. https://doi.org/10.1186/1471-2407-3-13.
13. Hiorns LR, Bradshaw TD, Skelton LA, Yu Q, Kelland LR, Leyland-Jones B.
Variation in RNA expression and genomic DNA content acquired during cell
culture. Br J Cancer. 2004;90(2):476–82. https://doi.org/10.1038/sj.bjc.
6601405.
14. Jones C, Payne J, Wells D, Delhanty JD, Lakhani SR, Kortenkamp A.
Comparative genomic hybridization reveals extensive variation among
different MCF-7 cell stocks. Cancer Genet Cytogenet. 2000;117(2):153–8.
https://doi.org/10.1016/s0165-4608(99)00158-2.
15. Bahia H, Ashman JN, Cawkwell L, Lind M, Monson JR, Drew PJ, Greenman J.
Karyotypic variation between independently cultured strains of the cell line
MCF-7 identified by multicolour fluorescence in situ hybridization. Int J
Oncol. 2002;20(3):489–94. https://doi.org/10.3892/ijo.20.3.489.
16. Kleensang A, Vantangoli MM, Odwin-DaCosta S, Andersen ME, Boekelheide
K, Bouhifd M, Fornace AJ Jr, Li HH, Livi CB, Madnick S, Maertens A,
Rosenberg M, Yager JD, Zhao L, Hartung T. Genetic variability in a frozen
batch of MCF-7 cells invisible in routine authentication affecting cell
function. Sci Rep. 2016;6:28994. https://doi.org/10.1038/srep28994.
17. Bustin SA. Absolute quantification of mRNA using real-time reverse
transcription polymerase chain reaction assays. J Mol Endocrinol. 2000;25(2):
169–93. https://doi.org/10.1677/jme.0.0250169.
18. Ginzinger DG. Gene quantification using real-time quantitative PCR: an
emerging technology hits the mainstream. Exp Hematol. 2002;30(6):503–12.
https://doi.org/10.1016/s0301-472x(02)00806-8.
19. Li L, Yan Y, Xu H, Qu T, Wang B. Selection of reference genes for gene
expression studies in ultraviolet B-irradiated human skin fibroblasts using
quantitative real-time PCR. BMC Mol Biol. 2011;12:8. https://doi.org/10.1186/
1471-2199-12-8.
20. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A,
Speleman F. Accurate normalization of real-time quantitative RT-PCR data
by geometric averaging of multiple internal control genes. Genome Biol.
2002;3(7):RESEARCH0034. https://doi.org/10.1186/gb-2002-3-7-research0034.
21. Lee KS, Alvarenga TA, Guindalini C, Andersen ML, Castro RM, Tufik S.
Validation of commonly used reference genes for sleep-related gene
expression studies. BMC Mol Biol. 2009;10:45. https://doi.org/10.1186/1471-
2199-10-45.
22. Jung M, Ramankulov A, Roigas J, Johannsen M, Ringsdorf M, Kristiansen G,
Jung K. In search of suitable reference genes for gene expression studies of
human renal cell carcinoma by real-time PCR. BMC Mol Biol. 2007;8:47.
https://doi.org/10.1186/1471-2199-8-47.
23. Rho HW, Lee BC, Choi ES, Choi IJ, Lee YS, Goh SH. Identification of valid
reference genes for gene expression studies of human stomach cancer by
reverse transcription-qPCR. BMC Cancer. 2010;10:240. https://doi.org/10.
1186/1471-2407-10-240.
24. Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, Kubista M, Mueller R,
Nolan T, Pfaffl MW, Shipley GL, Vandesompele J, Wittwer CT. The MIQE
guidelines: minimum information for publication of quantitative real-time
PCR experiments. Clin Chem. 2009;55(4):611–22. https://doi.org/10.1373/
clinchem.2008.112797.
25. Liu LL, Zhao H, Ma TF, Ge F, Chen CS, Zhang YP. Identification of valid
reference genes for the normalization of RT-qPCR expression studies in human
breast cancer cell lines treated with and without transient transfection. PLoS
One. 2015;10(1):e0117058. https://doi.org/10.1371/journal.pone.0117058.
26. Kılıç Y, Çelebiler AÇ, Sakızlı M. Selecting housekeeping genes as references
for the normalization of quantitative PCR data in breast cancer. Clin Transl
Oncol. 201416(2):184–90. https://doi.org/10.1007/s12094-013-1058-5.
27. Tilli TM, Castro Cda S, Tuszynski JA, Carels N. A strategy to identify
housekeeping genes suitable for analysis in breast cancer diseases. BMC
Genomics. 2016;17(1):639. https://doi.org/10.1186/s12864-016-2946-1.
28. Jo J, Choi S, Oh J, Lee SG, Choi SY, Kim KK, Park C. Conventionally used
reference genes are not outstanding for normalization of gene expression
in human cancer research. BMC Bioinformatics. 2019;20(Suppl 10):245.
https://doi.org/10.1186/s12859-019-2809-2.
29. Lyng MB, Laenkholm AV, Pallisgaard N, Ditzel HJ. Identification of genes for
normalization of real-time RT-PCR data in breast carcinomas. BMC Cancer.
2008;8:20. https://doi.org/10.1186/1471-2407-8-20.
30. Morse DL, Carroll D, Weberg L, Borgstrom MC, Ranger-Moore J, Gillies RJ.
Determining suitable internal standards for mRNA quantification of
increasing cancer progression in human breast cells by real-time reverse
transcriptase polymerase chain reaction. Anal Biochem. 2005;342(1):69–77.
https://doi.org/10.1016/j.ab.2005.03.034.
31. Krasnov GS, Kudryavtseva AV, Snezhkina AV, Lakunina VA, Beniaminov AD,
Melnikova NV, Dmitriev AA. Pan-Cancer Analysis of TCGA Data Revealed
Promising Reference Genes for qPCR Normalization. Front Genet. 2019;10:97.
https://doi.org/10.3389/fgene.2019.00097.
32. Gur-Dedeoglu B, Konu O, Bozkurt B, Ergul G, Seckin S, Yulug IG.
Identification of endogenous reference genes for qRT-PCR analysis in
normal matched breast tumor tissues. Oncol Res. 2009;17(8):353–65. https://
doi.org/10.3727/096504009788428460.
33. Jacob F, Guertler R, Naim S, Nixdorf S, Fedier A, Hacker NF, Heinzelmann-
Schwarz V. Careful selection of reference genes is required for reliable
performance of RT-qPCR in human normal and cancer cell lines. PLoS One.
2013;8(3):e59180. https://doi.org/10.1371/journal.pone.0059180.
34. Quiroz FG, Posada OM, Gallego-Perez D, Higuita-Castro N, Sarassa C,
Hansford DJ, Agudelo-Florez P, López LE. Housekeeping gene stability
influences the quantification of osteogenic markers during stem cell
differentiation to the osteogenic lineage. Cytotechnology. 2010;62(2):109–
20. https://doi.org/10.1007/s10616-010-9265-1.
35. Balwierz A, Czech U, Polus A, Filipkowski RK, Mioduszewska B, Proszynski T,
Kolodziejczyk P, Skrzeczynska-Moncznik J, Dudek W, Kaczmarek L, Kulig J,
Pryjma J, Dembinska-Kiec A. Human adipose tissue stromal vascular fraction
cells differentiate depending on distinct types of media. Cell Prolif. 2008;
41(3):441–59. https://doi.org/10.1111/j.1365-2184.2008.00531.x.
36. Maltseva DV, Khaustova NA, Fedotov NN, Matveeva EO, Lebedev AE,
Shkurnikov MU, Galatenko VV, Schumacher U, Tonevitsky AG. High-
throughput identification of reference genes for research and clinical RT-
qPCR analysis of breast cancer samples. J Clin Bioinforma. 2013;3(1):13.
https://doi.org/10.1186/2043-9113-3-13.
37. de Jonge HJ, Fehrmann RS, de Bont ES, Hofstra RM, Gerbens F, Kamps WA,
de Vries EG, van der Zee AG, te Meerman GJ, ter Elst A. Evidence based
selection of housekeeping genes. PLoS One. 2007;2(9):e898. https://doi.org/
10.1371/journal.pone.0000898.
38. Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative
C(T) method. Nat Protoc. 2008;3(6):1101–8. https://doi.org/10.1038/nprot.
2008.73.
39. Sweeney EE, McDaniel RE, Maximov PY, Fan P, Jordan VC. Models and
Mechanisms of Acquired Antihormone Resistance in Breast Cancer:
Significant Clinical Progress Despite Limitations. Horm Mol Biol Clin Investig.
2012;9(2):143–63. https://doi.org/10.1515/hmbci-2011-0004.
40. Coecke S, Balls M, Bowe G, Davis J, Gstraunthaler G, Hartung T, Hay R,
Merten OW, Price A, Schechtman L, Stacey G, Stokes W; Second ECVAM
Task Force on Good Cell Culture Practice. Guidance on good cell culture
practice. a report of the second ECVAM task force on good cell culture
practice. Altern Lab Anim. 2005;33(3):261–87. https://doi.org/10.1177/
026119290503300313.
41. NICEATM draft validation study report MCF-7 cell proliferation test method.
2012. https://ntp.niehs.nih.gov/iccvam/methods/endocrine/mcf7/mcf7-
valstudyreport-19jun12-wcv2-draft.pdf. Accessed Mar 2020.
42. Ochsner SA, Steffen DL, Hilsenbeck SG, Chen ES, Watkins C, McKenna NJ. GEMS
(Gene Expression MetaSignatures), a Web resource for querying meta-analysis
of expression microarray datasets: 17beta-estradiol in MCF-7 cells. Cancer Res.
2009;69(1):23–6. https://doi.org/10.1158/0008-5472.CAN-08-3492.
43. Hutter C, Zenklusen JC. The Cancer Genome Atlas: Creating Lasting Value
beyond Its Data. Cell. 2018;173(2):283–5. https://doi.org/10.1016/j.cell.2018.03.042.
44. Cooper LA, Demicco EG, Saltz JH, Powell RT, Rao A, Lazar AJ. PanCancer
insights from The Cancer Genome Atlas: the pathologist's perspective. J
Pathol. 2018;244(5):512–24. https://doi.org/10.1002/path.5028.
45. Kim JW, Kim SJ, Han SM, Paik SY, Hur SY, Kim YW, Lee JM, Namkoong SE.
Increased glyceraldehyde-3-phosphate dehydrogenase gene expression in
Jain et al. BMC Molecular and Cell Biology           (2020) 21:68 Page 18 of 19
human cervical cancers. Gynecol Oncol. 1998;71(2):266–9. https://doi.org/10.
1006/gyno.1998.5195.
46. Rondinelli RH, Epner DE, Tricoli JV. Increased glyceraldehyde-3-phosphate
dehydrogenase gene expression in late pathological stage human prostate
cancer. Prostate Cancer Prostatic Dis. 1997;1(2):66–72. https://doi.org/10.
1038/sj.pcan.4500208.
47. Schek N, Hall BL, Finn OJ. Increased glyceraldehyde-3-phosphate
dehydrogenase gene expression in human pancreatic adenocarcinoma.
Cancer Res. 1988;48(22):6354–9.
48. Tokunaga K, Nakamura Y, Sakata K, Fujimori K, Ohkubo M, Sawada K, Sakiyama
S. Enhanced expression of a glyceraldehyde-3-phosphate dehydrogenase
gene in human lung cancers. Cancer Res. 1987;47(21):5616–9.
49. Révillion F, Pawlowski V, Hornez L, Peyrat JP. Glyceraldehyde-3-phosphate
dehydrogenase gene expression in human breast cancer. Eur J Cancer.
2000;36(8):1038–42. https://doi.org/10.1016/s0959-8049(00)00051-4.
50. McNeill RE, Miller N, Kerin MJ. Evaluation and validation of candidate
endogenous control genes for real-time quantitative PCR studies of breast
cancer. BMC Mol Biol. 2007;8:107. https://doi.org/10.1186/1471-2199-8-107.
51. de Kok JB, Roelofs RW, Giesendorf BA, Pennings JL, Waas ET, Feuth T,
Swinkels DW, Span PN. Normalization of gene expression measurements in
tumor tissues: comparison of 13 endogenous control genes. Lab Invest.
2005;85(1):154–9. https://doi.org/10.1038/labinvest.3700208.
52. Solanas M, Moral R, Escrich E. Unsuitability of using ribosomal RNA as
loading control for Northern blot analyses related to the imbalance
between messenger and ribosomal RNA content in rat mammary tumors.
Anal Biochem. 2001;288(1):99–102. https://doi.org/10.1006/abio.2000.4889.
53. Johnson ML, Redmer DA, Reynolds LP. Quantification of lane-to-lane
loading of poly(A) RNA using a biotinylated oligo(dT) probe and
chemiluminescent detection. Biotechniques. 1995;19(5):712–5.
54. Spanakis E. Problems related to the interpretation of autoradiographic data on
gene expression using common constitutive transcripts as controls. Nucleic
Acids Res. 1993;21(16):3809–19. https://doi.org/10.1093/nar/21.16.3809.
55. Majidzadeh-A K, Esmaeili R, Abdoli N. TFRC and ACTB as the best reference
genes to quantify Urokinase Plasminogen Activator in breast cancer. BMC
Res Notes. 2011;4:215. https://doi.org/10.1186/1756-0500-4-215.
56. Pirsko V, Cakstina I, Priedite M, Dortane R, Feldmane L, Nakazawa-
Miklasevica M, et al. An effect of culture media on epithelial differentiation
markers in breast cancer cell lines MCF7, MDA-MB-436 and SkBr3. Medicina
(Kaunas). 2018;54(2):11. https://doi.org/10.3390/medicina54020011.
57. Untergasser A, Nijveen H, Rao X, Bisseling T, Geurts R, Leunissen JA.
Primer3Plus, an enhanced web interface to Primer3. Nucleic Acids Res. 2007;
35(Web Server issue):W71–4. https://doi.org/10.1093/nar/gkm306.
58. Colaprico A, Silva TC, Olsen C, Garofano L, Cava C, Garolini D, Sabedot TS,
Malta TM, Pagnotta SM, Castiglioni I, Ceccarelli M, Bontempi G, Noushmehr
H. TCGAbiolinks: an R/Bioconductor package for integrative analysis of
TCGA data. Nucleic Acids Res. 2016;44(8):e71. https://doi.org/10.1093/nar/
gkv1507.
59. Silva TC, Colaprico A, Olsen C, D'Angelo F, Bontempi G, Ceccarelli M,
Noushmehr H. TCGA Workflow: Analyze cancer genomics and epigenomics
data using Bioconductor packages. F1000Res. 2016;5:1542. https://doi.org/
10.12688/f1000research.8923.2.
60. Mounir M, Lucchetta M, Silva TC, Olsen C, Bontempi G, Chen X, Noushmehr
H, Colaprico A, Papaleo E. New functionalities in the TCGAbiolinks package
for the study and integration of cancer data from GDC and GTEx. PLoS
Comput Biol. 2019;15(3):e1006701. https://doi.org/10.1371/journal.pcbi.
1006701.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Jain et al. BMC Molecular and Cell Biology           (2020) 21:68 Page 19 of 19
